cyproheptadine has been researched along with Canine Diseases in 7 studies
Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
Excerpt | Relevance | Reference |
---|---|---|
"Cyproheptadine was given orally 12 to 14 hours before and again immediately before cisplatin administration." | 6.67 | Evaluation of butorphanol and cyproheptadine for prevention of cisplatin-induced vomiting in dogs. ( Berg, J; Dennis, RA; L'Heureux, DA; Moore, AS; Rand, WM, 1994) |
"Cyproheptadine was given orally 12 to 14 hours before and again immediately before cisplatin administration." | 2.67 | Evaluation of butorphanol and cyproheptadine for prevention of cisplatin-induced vomiting in dogs. ( Berg, J; Dennis, RA; L'Heureux, DA; Moore, AS; Rand, WM, 1994) |
"Cyproheptadine hydrochloride was administered orally at 0." | 2.67 | Failure of cyproheptadine hydrochloride as an antipruritic agent in allergic dogs: results of a double-blinded, placebo-controlled study. ( Cayatte, SM; Decker, GA; Miller, WH; Scott, DW, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Richkind, M | 1 |
Stolp, R | 1 |
Croughs, RJ | 1 |
Rijnberk, A | 1 |
Peterson, ME | 1 |
Kintzer, PP | 1 |
Moore, AS | 1 |
Rand, WM | 1 |
Berg, J | 1 |
L'Heureux, DA | 1 |
Dennis, RA | 1 |
Paterson, S | 1 |
Scott, DW | 1 |
Miller, WH | 1 |
Decker, GA | 1 |
Cayatte, SM | 1 |
Schwark, WS | 1 |
1 review available for cyproheptadine and Canine Diseases
Article | Year |
---|---|
Medical treatment of pituitary-dependent hyperadrenocorticism in dogs.
Topics: Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dog Diseases; Dogs; Drug Administration Sc | 1994 |
3 trials available for cyproheptadine and Canine Diseases
Article | Year |
---|---|
Evaluation of butorphanol and cyproheptadine for prevention of cisplatin-induced vomiting in dogs.
Topics: Animals; Butorphanol; Cisplatin; Cyproheptadine; Dog Diseases; Dogs; Dose-Response Relationship, Dru | 1994 |
Additive benefits of EFAs in dogs with atopic dermatitis after partial response to antihistamine therapy.
Topics: Animals; Chlorpheniramine; Clemastine; Cyproheptadine; Dermatitis, Atopic; Dog Diseases; Dogs; Drug | 1995 |
Failure of cyproheptadine hydrochloride as an antipruritic agent in allergic dogs: results of a double-blinded, placebo-controlled study.
Topics: Animals; Cyproheptadine; Dog Diseases; Dogs; Double-Blind Method; Female; Hyperphagia; Hypersensitiv | 1992 |
3 other studies available for cyproheptadine and Canine Diseases
Article | Year |
---|---|
Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine.
Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dog Diseases; | 1981 |
Results of cyproheptadine treatment in dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenal Cortex Hormones; Animals; Cushing Syndrome; Cyproheptadine; Dog Diseases; Dogs; Female; Hydr | 1984 |
Pharmacologic management of allergic diseases.
Topics: Administration, Oral; Administration, Topical; Anaphylaxis; Animals; Anti-Inflammatory Agents; Cromo | 1974 |